Safety and Efficacy of Topical NVC-422 Gel in Impetigo

PHASE2CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

December 31, 2010

Conditions
Impetigo
Interventions
DRUG

NVC-422

Dermal Gel applied 3 times per day for 7 days

Trial Locations (2)

Unknown

Hospital Infantil Dr. Robert Reid Cabral, Santo Domingo

Instituto Dermatológico, Santo Domingo

All Listed Sponsors
collaborator

Novum Pharmaceutical Research Services

INDUSTRY

collaborator

International Dermatology Research, Inc.

OTHER

lead

NovaBay Pharmaceuticals, Inc.

INDUSTRY